SCHEMBL3080799

SCHEMBL3080799

CCOC(=O)c1cc2c3occcc-3cc2[nH]1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.52
KDM4E B2RXH2 4/20 0.52
HPGD P15428 4/20 0.52
RAB9A P51151 3/20 0.52
LMNA P02545 3/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
NPC1 O15118 2/20 0.52
MEN1 O00255 2/20 0.52
GAA P10253 2/20 0.52
MAPT P10636 2/20 0.52
KMT2A Q03164 2/20 0.52
GLA P06280 1/20 0.52
ATM Q13315 1/20 0.52
HSD17B10 Q99714 2/20 0.47
MMP13 P45452 7/20 0.46
MMP2 P08253 5/20 0.46
MMP14 P50281 3/20 0.46
ALOX15 P16050 1/20 0.45
HTT P42858 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7325236 0.73 ALDH1A1 (0.56) ALDH1A1KDM4EHPGDRAB9ALMNA
SCHEMBL916058 0.72 SRD5A2 (0.49) ALDH1A1KDM4EHPGDRAB9ALMNA
SCHEMBL27886632 0.72 KDM4E (0.58) ALDH1A1KDM4EHPGDRAB9ALMNA
SCHEMBL12388694 0.72 KDM4E (0.46) ALDH1A1KDM4EHPGDRAB9ALMNA
SCHEMBL1171015 0.72 DAO (0.59) ALDH1A1KDM4EHPGDRAB9ALMNA
SCHEMBL701020 0.72 KDM4E (0.57) ALDH1A1KDM4EHPGDRAB9ALMNA
SCHEMBL22620711 0.70 KDM4E (0.56) ALDH1A1KDM4EHPGDRAB9ALMNA
SCHEMBL913891 0.70 KDM4E (0.56) ALDH1A1KDM4EHPGDRAB9ALMNA
SCHEMBL414099 0.70 BRAF (0.49) ALDH1A1KDM4EHPGDRAB9ALMNA
SCHEMBL1761178 0.70 POLB (0.57) ALDH1A1KDM4EHPGDRAB9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7795255-B2 Rigidified compounds for modulating heparanase activity INSIGHT BIOPHARMACEUTICALS LTD. (IL) 2010-09-14 US disclosed
US-20080039456-A1 Rigidified Compounds for Modulating Heparanase Activity INSIGHT BIOPHARMACEUTICALS LTD. (IL) 2008-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080039456-A1 Rigidified Compounds for Modulating Heparanase Activity HPSE, HEXA, GAA ALDH1A1 2428/4885KDM4E 2167/4885HPGD 1285/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.